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Abstract
Epigenetic changes, including histone modifications or chromatin remodeling are regulated by a large number of human
genes. We developed a strategy to study the coordinate regulation of such genes, and to compare different cell populations
or tissues. A set of 150 genes, comprising different classes of epigenetic modifiers was compiled. This new tool was used
initially to characterize changes during the differentiation of human embryonic stem cells (hESC) to central nervous system
neuroectoderm progenitors (NEP). qPCR analysis showed that more than 60% of the examined transcripts were regulated,
and .10% of them had a .5-fold increased expression. For comparison, we differentiated hESC to neural crest progenitors
(NCP), a distinct peripheral nervous system progenitor population. Some epigenetic modifiers were regulated into the same
direction in NEP and NCP, but also distinct differences were observed. For instance, the remodeling ATPase SMARCA2 was
up-regulated .30-fold in NCP, while it remained unchanged in NEP; up-regulation of the ATP-dependent chromatin
remodeler CHD7 was increased in NEP, while it was down-regulated in NCP. To compare the neural precursor profiles with
those of mature neurons, we analyzed the epigenetic modifiers in human cortical tissue. This resulted in the identification of
30 regulations shared between all cell types, such as the histone methyltransferase SETD7. We also identified new markers
for post-mitotic neurons, like the arginine methyl transferase PRMT8 and the methyl transferase EZH1. Our findings suggest
a hitherto unexpected extent of regulation, and a cell type-dependent specificity of epigenetic modifiers in
neurodifferentiation.
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Introduction
Chromatin structure is a major determinant of gene expression.
The transcriptionally active ‘‘open’’ euchromatin and the silenced
‘‘closed’’ heterochromatin are two major structural variants.
Increasing evidence points to intermediate forms which undergo
dynamic changes especially during development [1]. The
mechanisms determining access of transcription factors to their
regulatory sequences include DNA methylation [2], post-trans-
lational modifications (PTM) of histones [3] and chromatin
remodeling [4]. Histones, the most abundant chromatin proteins,
are the building blocks of the nucleosomes. The latter consist of
DNA wrapped around an octameric histone core [5]. Modifica-
tions of histones, and binding of further chromatin-associated
proteins act in concert with DNA methylation to regulate access to
the genetic information [6,7,8]. These control mechanisms that
are independent of the primary DNA sequence are jointly termed
‘‘epigenetics’’.
The enzymes catalyzing PTM of histones are classified as
‘‘writers’’. They promote acetylation, methylation and ubiquitina-
tion of specific lysine residues or the phosphorylation of serines
and threonines. Enzymes removing these histone marks, such as
KDM6B, act as ‘‘erasers’’ [3]. Different binding proteins, such as
the heterochromatin protein-1 (HP1) are recruited by specific
histone modifications [6]. These ‘‘readers’’ translate the code of
the histone marks into structural changes of the chromatin. For
many marks, e.g. the methylation of histone H3 at lysine 4
(H3K4me), multiple writers, readers and erasers are known [3].
Additional important players in chromatin dynamics are the multi-
subunit chromatin remodeling complexes, such as the BAF
complex, which can alter chromatin structure in an ATP-
dependent manner [4].
Although the first genome-wide maps of histone modifications
have been assembled for different human cell types [9,10,11], only
scarce information is available on the expression, function and role
of the different epigenetic regulators and modifiers during human
neurodevelopmental processes. Most information on neuronal
chromatin modifiers has been derived from neuroblastoma cell
lines [12], and data on non-transformed cells are mainly of rodent
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36708origin. Epigenetic mechanisms have been studied during mouse
development, both in vivo [13] and in differentiating murine
embryonic stem cells (ESC) in vitro [14,15]. These studies revealed
interesting information on the lineage-specific expression of some
chromatin remodelers such as the BAF complex. Its neural
progenitor stage-specific subunits (BAF45A, BAF53A) are ex-
changed for the neuron-specific (BAF45C, BAF53B) counterparts
[16].
Differentiating hESC represent an interesting new model system
to study early neural development, and allow the generation of
pure populations of early neuroectoderm CNS progenitors (NEP)
[17] and neural crest cells, progenitors of the PNS (NCP) [18,19].
In these systems, the gene expression changes of chromatin
modifiers occurring at different stages of development can be
characterized, and differences between PNS and CNS progenitors
may be identified.
In the present study we used bioinformatic methods and
literature evaluation to select genes covering the major families of
epigenetic modifiers and human chromatin associated proteins.
Then, we assembled a representative list of 150 candidates to be
studied. Their expression was quantified in human brain as well as
in two tightly-controlled differentiation models, resulting in NEP
and NCP cells, in order to investigate potential lineage- and stage-
specific gene expression patterns of epigenetic regulators, and to
validate the usefulness of the gene set for the characterization of
tissue-specific profiles.
Materials and Methods
Cultivation of the hESC line H9
H9 cells were cultivated in HES medium (DMEM/F12, 20%
knock-out serum replacement (KSR), 1x GlutaMax, 100 mM
MEM NEAA, 90 mM beta-mercaptoethanol and 10 ng/ml FGF-
2) on feeder cells (mouse embryonic fibroblasts (MEF)) at 37uC
and 5% CO2. Every five to six days the hESC colonies were
passaged by treatment with dispase for 9 min, and plated on MEF
that had been seeded one day before. Medium was changed daily.
The hESC WA09 (H9) was obtained from the Wisconsin
International Stem Cell Bank (WISC Bank). Import of the cells
and all experiments were carried out according to German
legislation under the license number 1710-79-1-4-27 of the
Robert-Koch Institute.
Differentiation of H9 to NEP
Differentiation towards NEP was performed as described before
[17], with the following minor change: instead of high noggin
concentrations, we used a combination of noggin and dorsomor-
phin [20]. From day 0 on, cells were grown in media containing
35 ng/ml noggin plus 600 nM dorsomorphin in addition to the
earlier described constituent SB 431542 (10 mM) [17]. On day 10
of differentiation, cells were quality-controlled by immunostaining.
Populations containing .90% PAX6-positive cells were harvested
for mRNA preparation.
Differentiation of H9 to NCP
The hESC line H9 was differentiated into NCP exactly as
described earlier by Lee et al. [18,19]. Briefly, cells were grown on
the stromal feeder cell line MS5 [56] in KSR medium without
FGF-2. After 3 days of differentiation, 500 ng/ml noggin were
added to the culture. After 4 additional days of differentiation,
KSR medium was additionally supplemented with sonic hedgehog
(Shh; 200 ng/ml) and fibroblast growth factor 8 (FGF-8; 100 ng/
ml). After 5 more days, medium was changed to DMEM/F12
medium containing N2 constituents [19] (N2 medium) supple-
mented with Shh, FGF-8, brain-derived neurotrophic factor
(BDNF, 20 ng/ml) and ascorbic acid (200 mM). On day 21,
rosettes were manually picked and transferred to poly-L-ornithine
(10 mg/ml), laminin (1 mg/ml) and fibronectin (1 mg/ml) coated
dishes. Cells were grown in N2 medium, supplemented with
BDNF, Shh, FGF-8 and ascorbic acid for 7 additional days. On
day 28, cells were FACS-purified, using positive sorting for cells
expressing HNK1 and p75. The population was always .90%
double-positive for the two NCP markers.
Human brain samples
The cortex of three neurologically healthy control individuals
(mean age 75610 years), provided by the German Brain-Net
(Munich, Germany) was used for analysis. Post-mortem cortex
samples had been obtain after written consent of the subjects and
the next of kin, in adherence to the guidelines laid down in the
Declaration of Helsinki on human research ethics. The use of the
material for this study was specifically approved by the IRB of the
University of Konstanz. RNA was extracted from frozen tissue and
converted to cDNA as described below.
Immunostaining
Cells were grown and differentiated on glass cover slips and
fixed with PBS, 4% para-formaldehyde, 2% sucrose for 15 min-
utes. After permeabilization with 0.2% Triton-x-100 in PBS for
7 minutes, the cells were blocked for one hour in blocking solution
(PBS, 1% BSA, 0.1% Triton-x-100). Primary and secondary
antibodies were diluted in blocking solution and incubated for one
hour each. DNA was stained with Hoechst-33342 and mounted
with Fluorsave reagent (Calbiochem).
Images were taken with an IX81 inverted microscope (Olym-
pus, Hamburg, Germany) equipped with a 40x air objective and
processed using Cell
P imaging software (Olympus). For confocal
microscopy, cover slips were mounted using Vectashield (contain-
ing DAPI), images were taken with a Zeiss LSM 510Meta confocal
microscope equipped with a Plan Apochromat 63x, NA 1.4 oil
DIC lens. Images were processed, using Adobe Photoshop CS2,
and antigens are displayed in false colors as indicated by the
antigen label in the figures.
Western blot analysis
Undifferentiated hESC and differentiated NEP were lysed in
2% SDS, followed by sonification to fragment genomic DNA.
Samples were separated on 18.7% gels by SDS-PAGE. Proteins
were transferred onto nitrocellulose membranes (Amersham;
Buckinghamshire, UK) using a BioRad WetBlot device. After 1
h blocking with 4% BSA in TBS containing 0.5% Tween-40
(TBS-T), membranes were incubated with primary antibodies over
night at 4uC. Following washing steps with TBS-T, membranes
were incubated with anti-rabbit-HRP (1:10000, Jackson Immuno
Research) for 1 h at RT. For visualization, ECL Western blotting
substrate (Pierce) was used. Used primary antibodies are listed in
Figure S1. Loading of equal amounts of histones was controlled by
staining for total H3.
Chromatin immuno precipitation
The chromatin immunoprecipitation assay on native chromatin
(N-ChIP) was performed according to the detailed protocol of
Umlauf and colleagues [21].
Briefly, for ChIP analysis either undifferentiated hESC or cells
on day 10 of differentiation were used. During MNase digestion,
the nuclei of 5610
6 cells were resuspended in 250 ml of digestion
buffer and treated for 12–14 min with 80 units of MNase at 25uC.
Chromatin Modifiers during Human Neurodevelopment
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36708For immunoprecipitation we used chromatin fractions consisting
of 1 to 5 nucleosomes and precipitated them with 2 mlo f
H3K4me3 (Millipore #17-614) and H3K27me3 (Active Motif
#39535), respectively. Data are presented as enrichment relative
to unspecific control.
Reverse transcription and quantitative qPCR
For reverse transcription quantitative PCR (qPCR) analysis,
RNA was extracted with the RNeasy mini Kit (Qiagen, Hilden,
Germany). The cDNA synthesis was performed using the cDNA
synthesis kit from SABiosciences or from Invitrogen. Primers were
designed (see Figure S1) according to the following requirements:
exon-spanning primers were designed manually and optimized for
melting temperature and primer dimerization by using the
Oligoanalyzer tool from IDT (http://eu.idtdna.com/analyzer/
applications-/oligoanalyzer/). Afterwards they were tested for
nonspecific amplification products through melt curve analysis and
agarose gel electrophoresis. All qPCRs were run in a Biorad Light
Cycler (Biorad, Mu ¨nchen, Germany) using the following settings:
16(10 min 95uC), 406(30 sec 95uC, 30 sec 60uC, 45 sec 72uC)
or the settings described for the RT
2 Profiler
TM PCR arrays by
SABiosciences. A large part of the primer sets used here is
available on pre-assembled plates as RT
2 Profiler
TM PCR Arrays
(‘‘Human Neurogenesis and Neural Stem Cell’’ (PAHS-404A),
‘‘Human Epigenetic Chromatin Modification Enzymes’’ (PAHS-
085A), and ‘‘Human Epigenetic Chromatin Remodeling Factors’’
(PAHS-086A), all from SABiosciences, Frederick, MD, USA).
Data in figures are shown as means 6 SEM of three independent
differentiations. For statistical analysis, we used the data calculated
with the DCt method and performed two-tailed t-test with Welch
correction for different variances between hESC, NEP, NCP or
cortex. In a second step we corrected the p-values for multiplicity
via Benjamini-Hochberg FDR (false discovery rate)-correction.
For p-values ,0.05, the regulation levels were assumed to be
significant and marked with an asterisk.
Normalization of qPCR data for cell type comparisons
The threshold cycle values (Ct) determined with the iQ5 optical
system software (Bio-Rad) were exported to Microsoft Excel for
further analysis. To evaluate the stability of the 5 reference genes
present on the array, the geNorm macro for Microsoft Excel was
used [22]. Gene expression stability (M) was calculated with
geNorm, and the genes were ranked from best to worst, based on the
M value. geNorm determines the individual stability of a gene within
a pool of genes, and calculates the stability according to the
similarity of their expression profile by pair-wise comparison, using
the geometric mean as a normalizing factor. The gene with the
highest M, i.e. the least stable gene, is then excluded in a stepwise
fashion until the most stable genes are determined. This way we
ended up with four reference genes (Actb/HPRT1/RPL13A/
GAPDH) that showed M-values ranging from 0.41 to 0.59
depending on the data set analyzed. Calculation of the relative
expression values (fold change or (2
2(DDCt))) of all genes was
performed using the comparative Ct method [23,24].
Affymetrix gene chip analysis
hESC were differentiated either towards NEP or NCP as
described above, and samples from approximately 5x10
6 cells
(hESC, NEP, NCP) were collected using RNAprotect reagent
from Qiagen. The RNA was quantified using a NanoDrop N-1000
spectrophotometer (NanoDrop, Wilmington, DE, USA), and the
integrity of RNA was confirmed with a standard sense automated
gel electrophoresis system (Experion, Bio-Rad, Hercules, CA,
USA). The samples were taken for transcriptional profiling when
the RNA quality indicator (RQI) number was .8. First-strand
cDNA was synthesized from 100 ng total RNA using an oligo-dT
primer with an attached T7 promoter sequence and then, the
complementary second strand was made. The double-stranded
cDNA molecule was used for in vitro transcription (IVT, standard
Affymetrix procedure) using Genechip 39 IVT Express Kit. As the
aRNA (amplified RNA, also commonly referred to as cRNA) is
being made, a biotinylated nucleotide analog is incorporated and
serves as a label for the message. After amplification, aRNA was
purified with magnetic beads, and 15 mg of aRNA were
fragmented with fragmentation buffer as per the manufacturer’s
instructions. Then, 12.5 mg fragmented aRNA were hybridized
with Affymetrix Human Genome U133 plus 2.0 arrays as per the
manufacturer’s instructions. The chips were placed in a GeneChip
Hybridization Oven-645 for 16 h at 60 rpm and 45uC. For
staining and washing, Affymetrix HWS kits were used on
a Genechip Fluidics Station-450. For scanning, the Affymetrix
Gene-Chip Scanner-3000-7G was used, and the image and quality
control assessments were performed with Affymetrix GCOS
software. All reagents and instruments were acquired from
Affymetrix (Affymetrix, Santa Clara, CA, USA). The generated
CEL files were taken for further statistical analysis. The authors
declare that microarray data are produced according to MIAME
guidelines and will deposited in MIAME upon acceptance of the
manuscript.
Bioinformatics and data analysis
Gene ontologies were investigated with the g:profiler web based
program (http:// biit.cs.ut.ee/gprofiler/) [25], using the GO
database with status from October 18th 2011.
The microarray data analysis workflow was assembled using the
Konstanz Information Miner open source software (KNIME;
www.knime.org [26]). The raw data was preprocessed using
Robust Multiarray Analysis (RMA) [27]. Background correction,
quantile normalization, and summarization were applied to all
expression data samples, using the RMA function from the affy
package of Bioconductor [28,29]. Low-expression genes with
a signal below an intensity of 64 in any one of the 12 conditions
were filtered out. The limma package (R & Bioconductor) was used
to identify differentially expressed genes [27], with hESC set as
control group. The moderated t-statistics was used for assessing the
raw significance of differentially expressed genes (NCP versus
hESC, hESC versus NEP). Then, final p-values were derived by
using the Benjamini-Hochberg method to control the false
discovery rate (FDR) [30] due to multiple hypothesis testing.
Transcripts with FDR adjusted p-value of #0.05 and a fold
change values $|2| were considered significantly regulated. The
hierarchical clustering analysis was performed as previously
described [31]. Average linkage was used as agglomeration rule
for the clustering analysis. Distances based on the Pearson’s
correlation coefficient was used to group together transcripts with
similar expression patterns across samples (rows of the heat map).
Distances based on Spearman’s rank correlations of the gene
expression values was used to measure the similarity between
samples. Then expression values within each row were normalized
as Z-factors, and color-coded accordingly.
For the visualization of qPCR data, generated with the DDCt
method, we implemented a heat map solution as graphical
representation. To express gene regulation, we used 256 steps for
blue (down-regulation) and red (up-regulation). The scaling was
adapted so that a manually chosen threshold value in each group
(e.g. 20-fold up-regulation) defined the maximum color saturation.
Then, color scaling steps were linearly mapped to gene regulation
values between 1 and the threshold value in red and below 1 in
Chromatin Modifiers during Human Neurodevelopment
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set to 1, were colored white and marked with letter ‘‘N’’ for not
regulated.
Results
Chromatin changes during the differentiation of hESC to
neuroectodermal progenitor cells
In order to investigate chromatin alterations and genetic
regulation during initial neural differentiation we used the recently
described hESC differentiation protocol towards neural epithelial
progenitor cells (NEP) [17]. Using this differentiation procedure
we obtained a pure and homogeneous cell populations in a fast
and synchronized manner.
Immunostaining was used for the characterization of culture
homogeneity. The hESC marker OCT4 was expressed in
undifferentiated hESC, but was not detectable in NEP (Fig. 1A).
Staining for the neural stem cell marker nestin, and for the NEP
marker PAX6 was observed in .90% of all NEP, but not in
hESC. As described by Chambers and colleagues [17], our
differentiated NEP culture contained ,2% of cells positive for the
neural crest marker HNK1 (Fig. 1A). qPCR analysis of several
neurodevelopmental markers also indicated that a neuroectoder-
mal cell population had been obtained from hESC. For instance,
PAX6 and the neural regulator gene NeuroD1 [32] were up-
regulated in NEP .500-fold compared to hESC (Fig. S2, S3).
Altogether, the phenotypic control of the differentiation procedure
indicates that we had obtained a relatively pure population of
NEPs.
To further validate this differentiation on gene expression level,
we obtained a genome-wide expression profile by microarray
analysis. The statistically most over-represented gene ontologies
(GO), amongst the genes that were up-regulated in NEP more
than 10 fold were all related to nervous system development
(Fig. 1B). The six most significant GOs yielded for instance the
categories ‘‘forebrain regionalization and development’’ and
’’nervous system development’’. This is in good agreement with
previous data describing this NEP population as rostral committed
CNS progenitor cells [17].
Transcriptional changes during the differentiation process are
expected to be associated with epigenetic changes as it is known
that epigenetic processes play a crucial role during cell differen-
tiation [33]. In order to characterize such changes in our
particular model system, we used various methods to characterize
histone modifications on different levels of cell organization. First,
we used Western blot analysis to quantify the global amount of
different histone modifications across the entire chromatin
(Fig. 1C). The overall levels of the various histone lysine
modifications evaluated for this purpose remained constant during
the differentiation independent of their property to activate
(H3K36me2, H3K4me3) or silence (H3K9me3, H3K27me3,
H4K20me3) gene expression. Secondly, the distribution of the
heterochromatin marker H3K9me3 within the nucleus was
analyzed by immunocytochemistry. The results showed, that
a dramatic redistribution within the nucleus occurred. In hESC,
H3K9me3 was localized in sharply-demarcated speckles, while the
staining was diffuse in NEP (Fig. 1D). This relocalization process
was confirmed by staining for another heterochromatin marker,
H4K20me3 (Fig. 1D). In contrast, H3K27me3 and euchromatin
marks (H3K4me3, H3K36me3, H3K9Ac) did not change their
localization pattern upon differentiation (data not shown). In
contrast to the western blot results the H3K9me3 immunostaining
looks as if H3K9me3 would increase upon differentiation. This
apparent discrepancy could either be due to the very dense
chromatin structure in the H3K9me3 spots in hESC or due to
high concentrations of H3K9me3 present in these heterochroma-
tin spots that are not adequately reflected by the immunostaining
method. Western blot analysis is in this case the more reliable
method to quantify protein amounts, and therefore we conclude
that there is no significant change in the overall extent of H3K9
methylation during differentiation. Thus, the altered spatial
organization of the histone marks was not due to overall changes
in the amount of heterochromatin and euchromatin. In a third
approach, we looked for histone alterations on the level of
individual genes. Chromatin immunoprecipitation was performed
for histone marks typically associated with silenced (H3K27me3)
or open gene promoters (H3K4me3). We have chosen these two
histone marks, as developmental regulator genes are described to
be in a poised state (ready for activation or silencing) through the
simultaneous presence of H3K4me3 and H3K27me3 [34,35]. The
data indicated that the pluripotency genes OCT4 and NANOG lost
their H3K4 tri-methylation upon differentiation. Moreover,
H3K27me3 was enriched in the OCT4 promoter, whereas NANOG
gained a bivalent status in NEP (Fig. 1E). Both types of changes
are consistent with the silencing of their respective genes during
the differentiation. In contrast, PAX6 was bivalently modified in
hESC, but lost the silencing H3K27me3 mark upon differentia-
tion. This is in agreement with up-regulation of this gene in NEP.
No such changes were found for the SOX2 gene, which is active
both in hESC and NEP (Fig. 1E). Altogether, these findings
indicate, that chromatin may change locally (nuclear regional
distribution) and gene-specifically, even though overall levels of
certain chromatin marks (Fig. 1C) or of the DNA CpG
methylation remain relatively constant [36]. We assumed that
these specific epigenetic changes would require the fine-tuning of
the activity of genes coding for enzymes that are specific for certain
differentiation states or groups of genes. As little is known about
such regulations, the major part of this study dealt with
a characterization of epigenetic modifier transcripts, using neural
differentiation as a test case.
Compilation of a set of genes involved in chromatin
modification
Initially, we used oligonucleotide high-density microarray-based
whole transcriptome analysis in hESC and NEP for data mining
concerning the regulation of epigenetic modifier genes. By manual
screening for few candidates, we found for instance DNMT3B to
be strongly down-regulated in NEP compared to hESC. This
correlated well with the function of this gene as pluripotent stem
cell marker [37]. The large and undefined amount of 400–600
(depending on definition or gene ontology included) known
epigenetic regulator genes makes it difficult to search for them
manually on a gene array data set. Also, systematic bioinformatic
analysis did not reveal an overrepresentation of a GO related to
chromatin modification. During this search process, we realized
that a GO comprising all epigenetic modifiers has not yet been
defined.
Therefore, we compiled and annotated here a set of such genes
that is a representative cross-section of epigenetic modifiers. For an
initial candidate list, we selected few positive controls such as
neuronal specific BAF subunits (BAF53B, BAF60C) or PRMT8.
These are either known to be expressed specifically in the brain or
to have a proven function during neural development, at least in
mouse model systems [16,38]. Then, we scanned the GOs dealing
with chromatin structure, histone modification, chromatin remo-
deling and DNA methylation. In combination with an extensive
literature search we chose a representative set of these genes. Few
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36708Figure 1. Effect of neuroectodermal differentiation on localization of histone marks. (A) hESC were differentiated towards NEP and
stained with antibodies specific for Oct4, HNK-1 (neural crest marker), Pax6 (NEP marker) and nestin (neural stem cell marker). Nuclei were stained
with the DNA dye H-33342 (blue). Scale bars: 100 mm. (B) GO analysis of the up-regulated genes in NEP compared to hESC (C) Whole cell extracts from
hESC and NEP were analyzed by Western blot with antibodies specific for the indicated histone H3 modifications. Total histone H3 (Pan-H3) was used
as loading control. (D) hESC and differentiated NEP were grown on glass cover slips and immunostained with antibodies specific for H3K9me3 or
H4K20me3. The upper panels show grey-scale signal intensities of the stain, the lower panels show a superimposition of the same histone stain as
above (red) with a DNA counter-stain (DAPI, blue). Arrows mark two cells with a diffuse H4K20me3 stain, which differs from the spot-like pattern
always observed in hESC. Scale bars: 10 mm. (E) Chromatin immunoprecipitiation was perfomed from nuclei of hESC or NEP with antibodies specific
for H3K4me3 and H3K27me3. The abundance of promoter regions of OCT4, NANOG, PAX6 and SOX2 was measured by qPCR with specific primers for
the indicated genes. Data were compared to control samples prepared without specific antibody and are indicated as relative enrichment. Data are
means 6 SD from 2 experiments.
doi:10.1371/journal.pone.0036708.g001
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domain homology to known epigenetic factors of the same family.
A total of 150 genes were selected according to the principles
described above. These also comprised potential positive control
markers for non-neuronal tissue, such as CDYL2 for the spleen
[39], CHD9 for osteogenesis [40] or HDAC11 for oligodentrocyte
differentiation [41]. The genes were classified according to their
functional role in epigenetic processes, and a graphical overview of
their mechanistic role was provided (Fig. 2). To make the
background information for the selected genes broadly available,
we compiled an extensive table that lists their supposed function as
well as the supporting evidence for this function, together with
relevant literature citations, and, if available, the genes’ potential
role in neurodevelopment (Fig. S4).
Pronounced changes of the epigenetic regulator
transcript profile during human neuroepithelial (NEP)
differentiation
We searched manually for these 150 genes on our whole
transcriptome microarray data set in hESC and NEP and found
22 genes to be regulated. This low amount of regulated genes was
very surprising, in addition these genes were also regulated to a low
level compared to neurodevelopmental genes (Fig. S3, S5). One
reason for this could be due to the far lower sensitivity of
microarray hybridization compared to qPCR. Therefore, we
decided to use qPCR analysis as alternative approach. The relative
expression changes of NEP vs. hESC were calculated from
averaged data of three independent differentiations, and then
visualized as a heat map (Fig. 3A). The full set of data including
statistics is added as supplementary information (Fig. S5). About
two thirds of the genes were up-regulated, and 16 of them reached
relative transcript levels of 5-fold to 30-fold compared to hESC.
For 68 of the genes, the relative expression levels identified by
microarray and qPCR correlated well as 14 genes were up-
regulated and 54 genes were not regulated with both methods.
However, the regulation of an equally large group of genes (n=72)
was identified only by qPCR (Fig. S6). We conclude that qPCR is
a more sensitive and specific approach for the quantification of
expression levels of this hand-picked selection of epigenetic
modifier genes. This was also supported by the observation that
the absolute expression levels detected by qPCR were mainly
below ten-fold which might not have been detected by microarray
hybridization. The remaining 10 genes that showed contradictory
expression levels in qPCR analysis compared to microarray
hybridization might be outliers that were not removed by
Figure 2. Compilation of 150 representative genes involved in epigenetic regulation. The genes were identified, selected, and classified
according to their function based on published literature and database searches. In a further step, the genes related to histone modifications were
sub-classified as writers (coding for modifying enzymes such as methyltransferases), as erasers (coding for de-modifying enzymes such as histone
deacetylases) and as readers (coding for proteins that bind to the respective modification).
doi:10.1371/journal.pone.0036708.g002
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also be due to wrong affymetrix annotations of these genes or due
to the analysis of different transcripts (splicing) of the same gene.
As one example for a class of enzymes regulated on the
transcriptional level, we chose histone deacetylases. Eight out of
the eleven isoforms present in our list were found to be up-
regulated at least 2-fold by qPCR. HDAC9 was regulated more
than 20-fold (Fig. 3B, S6).
Differentiation of hESC to neural crest precursor cells
(NCP)
To obtain some information on the specificity of the changes
observed, we generated a different neural precursor population. A
recently described protocol was used to generate a homogeneous
population of NCP [18,19], which was characterized by immu-
nocytochemistry. These peripheral nervous system precursors
were negative for the pluripotency marker OCT4 and the NEP
marker PAX6 (Fig. 4A). Instead, NCP were homogeneously
positive for the neural crest marker HNK-1 and the general neural
stem cell marker Nestin (Fig. 4A). Comparison of the whole-
genome transcript pattern of NCP with that of hESC and NEP
showed that we had generated a clearly distinct cell population.
Clustering analysis indicated a strong separation of NCP from
either hESC or NEP (Fig. 4B). The most-significantly over-
represented GOs of NCP comprised ‘‘nervous system develop-
ment’’, ‘‘extracellular matrix’’, and ‘‘skeletal system development’’.
This correlates well with the role of NCP as precursor for several
peripheral cell types, including cranial bone and cartilage [42]. In
addition the hierarchical clustering revealed a high reproducibility
between different hESC, NEP and NCP preparations.
To further confirm that we are differentiating hESC into two
different cell types we performed a gene expression analysis by
qPCR on 84 genes known to be involved in neurodevelopment
(Fig. S2). A comparison of the differentially regulated genes
(Fig. 4C) showed some pronounced differences between the cell
types. Some genes (e.g. PAX6) were up-regulated in NEP, but not
in NCP. Conversely, genes like BDNF were up-regulated in NCP,
and down-regulated in NEP. Amongst the genes jointly up-
regulated in NEP and NCP those that play a role in axonal growth
and guidance (PTN, NRP1, EFNB1) [43,44] were much stronger
up-regulated in NCP than in NEP (Fig. S5). In summary these
data show that NEP and NCP are indeed two different neural cell
populations, although both are derived from the same cell source.
Changes of the epigenetic regulator transcript profile
during differentiation of human pluripotent stem cells to
neural crest
When the expression levels of the 150 epigenetic modifiers
defined in figure 2 were measured in NCP, we found about 50
regulated genes and 15 transcripts with a relative abundance of
.5-fold relative to hESC. Indeed, we found besides genes that are
equally expressed also different genes expressed in the different cell
types. 13 genes were identified to be significantly regulated in
NCP, but not in NEP (Fig. 5), and 8 genes were up-regulated only
in NEP (Fig. S5). Amongst the NCP-specific genes was SMARCA2
(also called Brm), one of the ATPase subunits of the BAF complex
[4]. The differential up-regulation of this factor was also evident
from the microarray data (Fig. 4B; not shown), and this epigenetic
modifier is known to play a role in neurodevelopment and its
disorders [45]. A further differential regulation of chromatin
remodeling ATPases was observed for CHD7, which was down-
regulated in NCP, while it was up-regulated in NEP.
Figure 3. Transcriptional regulation of epigenetic modifiers
during neuroepithelial differentiation. (A) The levels of epigenetic
modifier transcripts of NEP and hESC were analyzed by qPCR in three
independent cell preparations, and relative abundances were calculat-
ed. The data were color-coded, with up-regulated genes displayed in
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levels in cortical neurons relative to stem cells and neural
precursors
We complemented the studies on early neurodevelopment with
a comparison of these cell populations to human cortical samples
(Ctx). For normalization of the results and for comparability with
the other cell populations, transcript levels in Ctx were displayed
relative to those in hESC. Of the 150 studied genes, 54 were
significantly higher expressed in Ctx, 5 showed lower expression
than in hESC (Fig. 6, S5).
About 20% of all genes examined were expressed higher in all
neural cell types (NEP, NCP, Ctx) than in hESC (Fig. 6A). Further
10% of the transcripts studied (n=16) were only up-regulated in
Ctx. These comprised for instance the arginine methyltransferase
PRMT8 [38] and BAF53B [16], bona fide examples of brain-
specific chromatin modifiers in other species (Fig. 6B). For a better
overview we displayed conspicuous cell type-specific genes, and
examples of those shared by more than one cell type in a table, in
which we sorted the genes according to their functional role in
epigenetic regulation (Fig. 6C). Interestingly, only few of these
genes are involved in histone methylation, phosphorylation or
DNA methylation. Although histone lysine methylation represents
the largest group of genes in our set of epigenetic modifiers, we
found only SETD7, a H3K4 HMT (histone methyl transferase), to
be differentially expressed in neural cells compared to hESC.
The three main groups of differentially expressed genes related
to chromatin remodeling, polycomb complexes and histone
acetylation. Therefore we assembled all investigated genes in-
volved in these three epigenetic processes. First, the expression
levels of components of BAF remodeling complexes were
compared (Fig. 7A). Interestingly, the subunits considered to be
specific for neural stem cells (BAF45A, BAF53A) were found to be
highly expressed in cortex samples. However, the neuron-specific
subunits (BAF60C and BAF53B) were expressed in Ctx at more
than an order of magnitude higher levels (several hundred-fold
compared to hESC) than BAF45A/BAF53A. A low, but
significant expression of BAF60C was here also observed in
NEP and NCP. This is in agreement with the literature as
expression of this subunit has also been described for murine
neural progenitor cells [16].
Next, we compared the expression levels of histone acetyl
transferases (HAT) and found pronounced up-regulations of
KAT2B (PCAF), MYST3 (MOZ), MYST4 (MORF) and NCOA1
(compared to hESC) in the other three cell types (Fig. 7B). This
may indicate a role in general neuro-development. Such a role has
indeed been shown for MYST4 and NCOA1 in murine model
systems. MYST4 was shown to be essential for neuronal de-
velopment of mouse cortex [46] and NCOA1 is elevated in murine
neural stem cells [47].
One of the most important epigenetic developmental regulators
is represented by the polycomb group family of proteins. These
proteins assemble two main complexes: PRC2 that methylates
H3K27 via the catalytic subunit EZH2 or EZH1, and PRC1 that
red and down-regulated genes in blue. Measures of variance and p-
values are indicated in supplemental material, and only significantly
regulated genes are displayed. Genes up-regulated .5-fold are
displayed in bold. (B) The transcript levels of HDACs were determined
for hESC, NEP, NCP and CTX. All expression levels of differentiated cells
were normalized to those of hESC, and relative abundances are
displayed. For instance, seven different HDACs were up-regulated in
NEP compared to hESC. The dotted lines indicate 2-fold regulation
levels. Data are means 6 SEM of three independent differentiations. *:
p,0.05
doi:10.1371/journal.pone.0036708.g003
Figure 4. Alternative early neural differentiation to neural crest
progenitors. (A) hESC were differentiated towards NCP and stained
with antibodies specific for OCT4 (no stain observed), PAX6 (no stain
observed), NESTIN and HNK-1. Cell nuclei were labeled with the DNA
dye Hoechst H-33342 (blue). Scale bars: 100 mm. (B) Pairwise
comparisons of hESC, NEP or NCP yielded 4277 differentially expressed
transcripts. The heat map displays the genes after clustering according
to the Pearson’s correlation of their expression values across samples.
The colors represent Z-scores of the row-wise normalized expression
values for each gene. The dendrogram indicates the pattern similarities
indicated by Spearman correlation distances (1- Spearman correlation
coefficient) and shows a large separation of NCP from NEP and hESC. (C)
The expression of early neuronal marker genes was measured in three
preparations each of hESC, NEP and NCP by qPCR. The transcript levels
of NEP and NCP were calculated relative to hESC. The relative gene
expression levels were color coded (significant down-regulation vs.
hESC in blue; significant up-regulation in red; non-significant changes
marked by ‘‘N’’. The genes showing different behavior in NEP vs NCP are
displayed. All measures of variance and p-values are indicated in the
supplemental material.
doi:10.1371/journal.pone.0036708.g004
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H2AK119 and establishes the dense heterochromatin structure
that is needed for gene silencing [48]. Among the components of
PRC1, we found a particular regulation pattern that is potentially
specific for the developmental stage and/or tissue: CBX7,
a homologue to CBX4 (Pc2) was up-regulated only in Ctx, but
not in NEP or NCP. In addition, CBX8, a further particular
isoform of CBX4, was up-regulated in all three cell types (Fig. 7C).
This may indicate a neuron-specific role for CBX7 and a more
general neuronal role for CBX8.
Most interestingly, we found a pronounced differential regula-
tion pattern for the two isoforms of the PRC2-associated H3K27
methyl transferase. In Ctx, EZH2 was down-regulated, while
EZH1 was strongly up-regulated (Fig. 7D). For murine in vitro and
in vivo systems it was reported that EZH2 is exchanged with EZH1
in fully differentiated non-proliferative tissue [49]. Moreover, the
methylation of H3K27 catalyzed by EZH1-containing PRC2
complex results in a very dense chromatin structure, while
chromatin methylated at H3K27 by EZH2-PRC2 does not
change its higher order structure significantly [49].
Discussion
In this study, we used two homogeneous and well-controlled
neural differentiation systems to examine hitherto unknown
regulations of the large set of genes coding for epigenetic
regulators. The early precursor cells were further compared to
cortical tissue. Thus, the cell types used to explore changes of
chromatin modulators on the transcriptional level spanned
developmental stages from embryonic stem cells to post-mitotic
neurons. Our findings of pronounced cell type-specific regulations
of the transcripts coding for chromatin-modifying proteins
complement other types of approaches to study epigenetic
regulations. While most previous studies have focused on the
chromatin itself, by investigating histone modifications, DNA
methylation patterns or the spatial chromatin structure, we
investigated the expression levels of the genes catalyzing the
above mentioned chromatin alterations.
For the initial characterization of the experimental systems used,
we chose several traditional endpoints. For instance, some histone
modifications were studied directly by Western blot and
immunostaining. Although the global amount of methylated
histones did not change during neural differentiation, the sub-
nuclear distribution of such histone marks, as well as their
abundance on individual promoters underwent striking changes.
In parallel with the down-regulation of the stem cell markers
OCT4 and NANOG upon differentiation of hESC to NEP, the
enrichment of H3K4me3 in their promoter region was reduced. In
the same vein, the up-regulation of the neuroectoderm marker
PAX6 was paralleled by a loss of the repressing H3K27me3 mark
in its promoter (Fig. 1). However, very little is known about the
transcriptional regulation of the enzymes responsible for such
chromatin changes. Because the group of genes involved in
Figure 5. Regulation of epigenetic modifiers in NCP, and their comparison to NEP. The levels of epigenetic regulator gene transcripts were
measured in hESC, NCP and NEP by qPCR, and the expression levels were calculated relative to the levels in hESC. All genes that showed significant
up- or downregulation in NCP compared to hESC are displayed. The relative expression level (vs. hESC) was color coded, as illustrated in the
chromatic scale in the bottom. Genes with .5-fold expression in NCP vs. hESC are shown in bold. For better comparison, the data for the same genes
are shown for NEP in the right-hand column. Measures of variance and p-values are indicated in the supplemental material.
doi:10.1371/journal.pone.0036708.g005
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tissue specific expression studies have been performed [9,10,11],
and these are mostly limited to mouse models or lower vertebrates.
The set of epigenetic modifiers selected and characterized here
should help to facilitate more studies on human tissue expression.
Many different proteins have been described to be directly or
indirectly involved in opening or closing the chromatin structure,
and therefore providing or inhibiting access for the transcriptional
machinery. Complexity is added by synergistic and antagonistic
actions of many factors, by the formation of multi-protein
complexes with exchangeable subunits, and by the involvement
of one given factor in multiple complexes and reactions [4,16].
Particularly important for our study is the feature that often one
specific chromatin modification can be set by several different
enzymes. For example, more than 15 different histone methyl-
transferases are known to catalyze the methylation of lysine 4 of
H3 [3]. Therefore it was interesting, that among the 8 H3K4
HMT, only the H3K4 histone methyltransferase SETD7 was
strongly up-regulated in both the neural precursor populations and
in cortical tissue (Fig. 6). This indicates that this specific enzyme
may play a particular role in regulating neural genes.
Also the BAF chromatin remodeler multi-protein complexes
contain different alternative ATPase subunits, such as SMARCA2
and SMARCA4 [4]. It is still unclear, under which circumstances
these subunits are assembled into the BAF complex. Here we
found cell-type specific regulation of these subunits (Fig. 6). The
differential use and transcriptional regulation of chromatin
remodelers may help in the future to characterize different cell
types and developmental stages. Combined with more detailed
future knowledge of preferred targets, e.g. of SETD7 or
SMARCA2-containing complexes, cell-specific maps of their
transcriptional regulation may complement other approaches to
yield information on differential epigenetic regulations. The
foremost outcome of the suggested PCR-based analysis will be
a fast and efficient strategy for screening different tissues or cell
types for differences of regulation on the transcriptional level. This
may yield interesting fingerprints as such. In addition, this
approach could be used as a first screen to identify candidates
for more in depth examination of epigenetic modifiers. The
subsequent studies would then address the functional relevance of
the gene products. This would require more information on
protein levels, on post-translational modifications of the respective
proteins and also of their association with different multi-protein
complexes.
During the course of this study, we tested different approaches
to define a useful set of epigenetic modifiers. Initially, we looked up
the genes that are included in the most obvious epigenetic GOs
(‘‘histone modification’’, ‘‘chromatin organization’’, ‘‘chromatin
remodeling’’). We realized that many of the genes included in
these GOs did not fulfill our criteria for an epigenetic modifier, i.e.
the literature did not support their direct role in epigenetic
modifications or regulations. For example, the genes coding for
nitric oxide synthase or IL-1 were included in this list. Study of the
primary literature for many more genes showed that the
supporting evidence for a predominant role in epigenetics was
often not solid. Part of the information included in the GO
database is assembled in initial stages by data mining algorithms
that screen scientific publications according to key words. This
approach works very well for clearly defined biological areas such
as ‘‘carbohydrate metabolism’’. It works less well for epigenetic
regulator genes, as many different processes impact on epigenetics
and vice versa. This can easily lead to an erroneous classification of
an epigenetically regulated gene as epigenetic regulator. More-
over, many enzymes like the above-mentioned nitric oxide
Figure 6. Comparison of epigenetic modifiers in cortical
neurons with early neural precursors. The levels of epigenetic
regulator gene transcripts were measured as in Fig. 5, but samples from
human cortex (CTX) were included. Up-regulated genes are displayed in
red, down-regulated transcripts in blue, as indicated by the chromatic
scale. Genes with CTX transcript levels 5 times higher than in hESC are
indicated in bold letters (A) Display of all genes regulated into the same
direction in early neural precursors and mature neurons. (B) Differen-
tially regulated genes. Measures of variance and p-values are indicated
in the supplemental material. (C) Summary of the most up-regulated
common (italics) or cell type-specific (red, underlined) chromatin
modifier genes, sorted according to their function.
doi:10.1371/journal.pone.0036708.g006
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although this may not be their major physiological role.
Due to these problems, we hand-picked here a set of 150
epigenetic regulators genes after careful study of the literature. The
list consists of players involved in all major groups of epigenetic
mechanisms. We are aware of the fact that a more exhaustive list
would rather contain about 1000 genes. Such a list would certainly
be more complete, but it would also contain several disputable
candidates, and it would be much harder to handle. We took here
the practical approach to validate the applicability of our set of
genes to confirm some known candidates. Our list included some
epigenetic regulator genes that have known roles in vertebrate and
non-vertebrate neuronal development or are expressed specifically
in the brain in mouse model systems. The relative expression levels
of these genes in our study provided first evidence for the
usefulness of our set of genes. For instance, our data showed that
PRMT8, BAF53B and CHD5 were exclusively or very highly
expressed in human cortex tissue (out of the cell types examined).
This agrees with information for mouse tissue [16,38,51], and we
show here for the first time that these genes are also highly
expressed in human brain.
At present, very little is known about epigenetic regulator genes
that may be specific for non-neuronal tissues. Most knowledge is
derived from knockout mice that show developmental defects
upon knock down of a specific regulator gene. On this basis, some
candidates in our list of genes may be up-regulated in other
differentiation systems, during the generating of other cell types/
tissues. For instance, CHD9 was reported to be involved in
osteogenic cell differentiation [40], and CDYL2 is expressed
highly in testis, prostate, spleen and leukocytes [39]. For the
examination of new tissues, these may be used as positive controls.
However, this will have to be paralleled by the choice of a set of
tissue-specific differentiation markers (similar to PAX6, Nestin and
NeuroD1 for NEP), which can then be used as overall positive
controls for the correct differentiation and correct analysis
procedure.
We also tested the ability of the gene modifier set to identify new
differential patterns in related cell populations, such as different
neural precursors or neural precursors vs. post-mitotic neurons. As
we identified, in general, astonishing cell type differences, and
differential expression patterns, for the genes that are yet little
characterized, we conclude that the chosen set of modifiers
represents a useful tool and starting point for future studies.
The major groups of genes that we found to be highly-expressed
throughout neuronal development, were involved in histone
acetylation, chromatin remodelling and PRC complex compo-
Figure 7. Synopsis of the regulation of different epigenetic modifier groups at different stages of neuronal differentiation. Four
groups of epigenetic modifiers were selected for a comparison of relative expression levels of NEP, NCP and CTX. Data were obtained, and
significances calculated as described earlier. All data are means 6 SEM of three independent differentiations. (A) Genes that code for subunits of the
BAF remodeling complex. (B) Genes that code for histone acetyl transferases (HAT). (C, D) Genes that are involved in PRC1 and PRC2 complex
formation. *: p,0.05 vs hESC transcript level.
doi:10.1371/journal.pone.0036708.g007
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SETD7, was strongly regulated. Further interesting changes
involved ATPase subunits of chromatin remodelling complexes:
CHD7 and SMARCA2 showed cell-specific expression profiles. In
NEP, CHD7 was up- and in NCP it was down-regulated. It is
known that this chromodomain protein is required for the
differentiation of hESC to early NCP and for frog neural crest
formation [52]. However, it is unclear, whether the gene still plays
a role in developed neural crest cells or their progeny. Our findings
of a relative down-regulation (also confirmed by microarray
analysis; not shown) may indicate that CHD7 is less important,
once NCP have developed, expanded and undergone epithelial-to-
mesenchymal transition (as the cells used here). In contrast to
CHD7, SMARCA2 was up-regulated in NCP but not in NEP. This
data may indicate a role of the ATPase in NCP cells, but we are
aware of the fact that knowledge on protein levels and functional
data would be required for a more definite statement.
Another example for cell type-specific expression differences
was found for members of the PRC1 complex. The canonical
CBX4 (Pc2) subunit of PRC1, that binds the H3K27me mark
[48,53], was neither regulated during early differentiations
towards NEP and NCP nor was it highly expressed in the
cortex. Instead, we found CBX8 to be up-regulated in all
investigated cell types, and CBX7 to be highly expressed in
cortex, while the levels in other cells resembled those in hESC.
Therefore, the CBX4 homologue CBX7, may have a specific
role in adult brain. We also obtained evidence suggesting a cell-
type-specific subunit switch in the PRC2 complex. EZH2, the
methyl transferase catalyzing the H3K27me3 modification, is
expressed in the two progenitor cell types (NEP and NCP), but
its expression was low in cortex, compared to hESC. Instead, its
isoform EZH1 was highly expressed in the adult tissue. In-
terestingly, it has been shown for mouse cells that chromatin
methylated by EZH1 had a much denser structure than
chromatin methylated by EZH2 [49]. However, the exact
function of EZH1 is not fully clarified yet. Recently, EZH1
was reported to co-localize with active histone modification
H3K4me3 indicating a different function of PRC2-EZH1
complex [54].
In summary, we compiled a representative set of 150 genes
involved in epigenetic regulation of gene expression. This list is
only a small reflection of the hundreds or even up to thousand
genes that have been described to be involved in epigenetics. The
set presented here can still be handled easily, and it has been
shown to be useful to indicate changes due to differentiation.
This provides a basis for more detailed investigations of certain
candidates or more comprehensive investigation of certain groups
of genes. With this study, we have added a new approach to
characterize the epigenetic status of a cell or tissue. It may be
comparable to the characterization of transcription factor
networks [55,56] or transcriptional profiling in other areas of
cell biology [24,57,58,59]. In all such cases the information on
the actual state of cellular constituents (in our case: chromatin) is
very limited, and the absolute expression levels of what is
measured are hard to interpret, but the relative changes and
their dynamics can yield useful descriptions of a biological
system, and define a level of information not easily obtained by
other methods. This may be particularly interesting for
toxicology, for the characterization of diseased tissue, and for
the comparison of different cell populations generated in vitro.
Supporting Information
Figure S1 Antibodies used for immunstaining and
primers used for qPCR.
(PDF)
Figure S2 Neurodevelopmental genes examined in this
study. The neurodevelopmental genes investigated in this study
by qPCR are listed alphabetically by their gene symbol. The
cDNAs are defined by the respective RefSeq accession numbers
(as used in NCBI data bases). Alternative gene names frequently
used in the literature have been added in paretheses. The
references provide further background information.
(PDF)
Figure S3 Expression of neuro-developmental genes in
NEP and NCP. hESC were differentiated into NEP or NCP.
RNA was prepared from all types and qPCR was performed using
primers specific for the indicated neurodevelopmental regulator
genes. Threshold cycle values (Ct) were measured with a Biorad
light cycler. Ct values were normalized to house keeping genes,
and relative gene expressions were calculated by normalization to
hESC expression levels. Data are means of three independent
differentiations +/2 standart deviation (SD). p-values were
calculated with Students t-test and corrected for false discovery
rate (FDR) according to Benjamini-Hochberg. They correspond to
the statistical difference from the expression levels in hESC. Data
corresponds to Fig. 4C.
(PDF)
Figure S4 150 Epigenetic regulators examined in this
study. The epigenetic regulator genes investigated in this study by
qPCR are listed alphabetically by their gene symbol. The cDNAs
are defined by the respective RefSeq accession numbers (as used in
NCBI data bases). Alternative gene names frequently used in the
literature have been added in paretheses. The references provide
further background information.
(PDF)
Figure S5 Expression of epigenetic regulators normal-
ized to hESC. hESC were differentiated into NEP or NCP.
RNA was prepared from all types or cortical tissue samples.
qPCR was performed using primers specific for the indicated
neurodevelopmental regulator genes. Threshold cycle values (Ct)
were measured with a Biorad light cycler. Ct values were
normalized to house keeping genes, and relative gene expressions
were calculated by normalization to hESC expression levels.
Data are means of three independent differentiations +/2
standart deviation (SD). p-values were calculated with Students t-
test and corrected for false discovery rate (FDR) according to
Benjamini-Hochberg. They correspond to the statistical differ-
ence from the expression levels in hESC. Data corresponds to
Fig. 2, 5, 6, and 7.
(PDF)
Figure S6 Comparison of relative expression data from
microarray and qPCR. hESC were differentiated into NEP,
and RNA was prepared from undifferentiated hESC and NEP.
qPCR was performed using primers specific for the 150 epigenetic
regulator genes and threshold cycle values (Ct) were measured
with a Biorad light cycler. Ct values of NEP were first normalized
to house keeping genes. Fold expression levels were obtained by
further normalization to hESC (Fig. S5). RNA for microarray was
prepared as described above and hybridization on Affymetrix gene
chips was perfomed. After bioinformatic analysis, we obtained
expression levels relative to hESC. Microarray data were screened
for our set of 150 epigenetic regulator genes investigated by qPCR.
Chromatin Modifiers during Human Neurodevelopment
PLoS ONE | www.plosone.org 12 May 2012 | Volume 7 | Issue 5 | e36708Fold expression values obtained from microarray data are blotted
on the y-axis, and fold expression levels obtained from qPCR are
blotted on the x-axis. For both data sets, non- significant values
were set to 0. n: amount of genes in the different groups. Dotted
lines indicate 2-fold regulations.
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